AIMS/HYPOTHESIS: The physiological increase in muscle protein anabolism induced by insulin is blunted in healthy, glucose-tolerant older adults. We hypothesised that the age-related defect in muscle protein anabolism is a true insulin resistance state and can be overridden by supraphysiological hyperinsulinaemia. METHODS: We used dye dilution, stable isotopic and immunoblotting techniques to measure leg blood flow, muscle protein synthesis, protein kinase B/mammalian target of rapamycin (Akt/mTOR) signalling, and amino acid kinetics in 14 healthy, glucose-tolerant older volunteers at baseline, and during an insulin infusion at postprandial (PD, 0.15 mU min(-1) 100 ml(-1)) or supraphysiologically high (HD, 0.30 mU min(-1) 100 ml(-1)) doses. RESULTS: Leg blood flow, muscle protein synthesis, and Akt/mTOR signalling were not different at baseline. During hyperinsulinaemia, leg blood flow (p < 0.01) and muscle protein synthesis increased in the HD group only (PD [%/h]: from 0.063 +/- 0.006 to 0.060 +/- 0.005; HD [%/h]: from 0.061 +/- 0.007 to 0.098 +/- 0.007; p < 0.01). Muscle Akt phosphorylation increased in both groups, but the increase tended to be greater in the HD group (p = 0.07). The level of p70 ribosomal S6 kinase 1 (S6K1) phosphorylation increased in the HD group only (p < 0.05). Net amino acid balance across the leg improved in both groups, but a net anabolic effect was observed only in the HD group (p < 0.05). CONCLUSIONS/ INTERPRETATION: We conclude that supraphysiological hyperinsulinaemia is necessary to stimulate muscle protein synthesis and anabolic signalling in healthy older individuals, suggesting the existence of a true age-related insulin resistance of muscle protein metabolism.
AIMS/HYPOTHESIS: The physiological increase in muscle protein anabolism induced by insulin is blunted in healthy, glucose-tolerant older adults. We hypothesised that the age-related defect in muscle protein anabolism is a true insulin resistance state and can be overridden by supraphysiological hyperinsulinaemia. METHODS: We used dye dilution, stable isotopic and immunoblotting techniques to measure leg blood flow, muscle protein synthesis, protein kinase B/mammalian target of rapamycin (Akt/mTOR) signalling, and amino acid kinetics in 14 healthy, glucose-tolerant older volunteers at baseline, and during an insulin infusion at postprandial (PD, 0.15 mU min(-1) 100 ml(-1)) or supraphysiologically high (HD, 0.30 mU min(-1) 100 ml(-1)) doses. RESULTS:Leg blood flow, muscle protein synthesis, and Akt/mTOR signalling were not different at baseline. During hyperinsulinaemia, leg blood flow (p < 0.01) and muscle protein synthesis increased in the HD group only (PD [%/h]: from 0.063 +/- 0.006 to 0.060 +/- 0.005; HD [%/h]: from 0.061 +/- 0.007 to 0.098 +/- 0.007; p < 0.01). Muscle Akt phosphorylation increased in both groups, but the increase tended to be greater in the HD group (p = 0.07). The level of p70 ribosomal S6 kinase 1 (S6K1) phosphorylation increased in the HD group only (p < 0.05). Net amino acid balance across the leg improved in both groups, but a net anabolic effect was observed only in the HD group (p < 0.05). CONCLUSIONS/ INTERPRETATION: We conclude that supraphysiological hyperinsulinaemia is necessary to stimulate muscle protein synthesis and anabolic signalling in healthy older individuals, suggesting the existence of a true age-related insulin resistance of muscle protein metabolism.
Authors: Lucy H Clerk; Michelle A Vincent; Jonathan R Lindner; Michael G Clark; Stephen Rattigan; Eugene J Barrett Journal: Diabetes Metab Res Rev Date: 2004 Jan-Feb Impact factor: 4.876
Authors: Gregory C Henderson; Ketan Dhatariya; G Charles Ford; Katherine A Klaus; Rita Basu; Robert A Rizza; Michael D Jensen; Sundeep Khosla; Peter O'Brien; K Sreekumaran Nair Journal: FASEB J Date: 2008-09-30 Impact factor: 5.191
Authors: Michelle A Vincent; Lucy H Clerk; Jonathan R Lindner; Alexander L Klibanov; Michael G Clark; Stephen Rattigan; Eugene J Barrett Journal: Diabetes Date: 2004-06 Impact factor: 9.461
Authors: Thomas W Buford; Stephen D Anton; Andrew R Judge; Emanuele Marzetti; Stephanie E Wohlgemuth; Christy S Carter; Christiaan Leeuwenburgh; Marco Pahor; Todd M Manini Journal: Ageing Res Rev Date: 2010-05-14 Impact factor: 10.895
Authors: Tatiana Moro; Camille R Brightwell; Rachel R Deer; Ted G Graber; Elfego Galvan; Christopher S Fry; Elena Volpi; Blake B Rasmussen Journal: J Nutr Date: 2018-06-01 Impact factor: 4.798
Authors: E Lichar Dillon; Shanon L Casperson; William J Durham; Kathleen M Randolph; Randall J Urban; Elena Volpi; Masood Ahmad; Michael P Kinsky; Melinda Sheffield-Moore Journal: Am J Physiol Regul Integr Comp Physiol Date: 2011-08-31 Impact factor: 3.619
Authors: Mary Ann Johnson; Johanna T Dwyer; Gordon L Jensen; Joshua W Miller; John R Speakman; Pamela Starke-Reed; Elena Volpi Journal: J Nutr Date: 2011-01-26 Impact factor: 4.798
Authors: E L Kullman; W W Campbell; R K Krishnan; K E Yarasheski; W J Evans; J P Kirwan Journal: Int J Sports Med Date: 2013-01-16 Impact factor: 3.118